Top 20 pharmaceutical manufacturers in Egypt
© Egypt Business
.
| Company | Founded | Company description |
|---|---|---|
| 1997 | Global Napi Pharmaceuticals (GNP) is a branded generic pharmaceutical manufacturer with three EMA approved manufacturing facilities in Egypt. | |
| 1997 | EVA Pharma is one of the leading branded generic pharmaceutical manufacturers in the EMEA region. | |
| 1987 | The Company is one of the dominant players in the pharmaceutical industry in Egypt, the Middle East and Africa. | |
| 1998 | Amoun is among Egypt's largest companies producing human and veterinary pharmaceutical products and food supplements. | |
| 1997 | APEX Pharma S.A.E. is an Egyptian Joint Stock company. Main activities include Production, Marketing, Sales & Importation of pharmaceutical products. | |
| 1994 | Egyptian pharmaceutical company producing a wide range of branded generic pharmaceuticals, nutraceuticals, food supplements and veterinary products. | |
| 1958 | Minapharm ranks among the leading pharmaceutical companies in Egypt and the Middle East. | |
| 1986 | Mash Premiere is a leading pharmaceutical company in the Egyptian market aiming to improve the quality of life for the whole MENA Region. | |
| 1995 | Pharmaoverseas was founded as a distribution company in 1995 by Dr. Ahmad Gazzarine. | |
| 1988 | SEDICO is one of the pioneer pharmaceutical drug producers with products like insulin, biotechnology products and many others drugs. | |
| 2001 | Ibnsina Pharma provides pharmacy and manufacturer services. Services include distribution, order taking and delivery, promotion, and warehousing | |
| 1972 | Chemipharm is the next generation pharmaceuticals & Fast Moving Consumer Goods (FMCG) company. | |
| 2002 | MACRO GROUP Pharmaceuticals is a cosmeceutical company that was established in 2002 with its headquarters located in Cairo. | |
| 2007 | Inspire pharma is a national Egyptian pharmaceutical company established in 2005, founded by a determined group of partners. | |
| 2008 | Our Vision,to be an ideal company that provides high quality pharmaceutical products and services on scientific and ethical basis. | |
| 2016 | One of the leading pharmaceuticals and nutraceuticals producers in the Egyptian Market. | |
| 2006 | AUG Pharma is a pharmaceutical company that aims to help people lead a better life by providing real value medicines. | |
| 1964 | Marcyrl's Vision is being one of the largest leading Pharmaceutical Company in Egypt and taking a place all over the World. | |
| 1978 | Liptis Pharmaceuticals global presence has helped to enhance the quality of life of patients by promoting high-quality lifesaving medication. | |
| 2001 | Leading the market in all the selected therapeutic areas we serve, by offering value added products portfolios at optimum price. | |
| 1980 | EIPICO is a public shareholding company operating in the pharmaceuticals industry. |
In 2023, Egypt's pharmaceutical industry achieved remarkable milestones, solidifying its position as a global leader and a dominant force in the Middle East and North Africa (MENA) region. With a market value of $56.6 billion, Egypt claimed the top spot in the MENA pharmaceutical market, surpassing all expectations.
One of the key factors contributing to Egypt's pharmaceutical dominance is its unique dual role as both the largest producer and consumer of pharmaceuticals in the region. This distinction has enabled Egypt to nurture a robust domestic pharmaceutical industry, not only catering to its own population but also exporting pharmaceutical raw materials worth $400 million annually to the global market.
A strategic advantage that sets Egypt apart as a pharmaceutical powerhouse is its abundant mineral resources, which play a vital role in drug manufacturing. These resources ensure a cost-effective and sustainable production process, making Egypt an attractive destination for pharmaceutical companies seeking to invest in the sector.
Egypt's commitment to further enhancing its pharmaceutical capabilities is evident in initiatives such as securing funding from banks to support research and development (R&D) efforts within local pharmaceutical companies. This investment in R&D is expected to lead to innovative drug development and advanced pharmaceutical technologies, strengthening Egypt's position as a global pharmaceutical leader.
Despite these remarkable achievements, there have been concerns about the shortage of certain medications, especially those used for chronic illnesses like diabetes, blood thinners, and common cold remedies. Egypt faces the challenge of meeting the growing demand for healthcare, particularly in light of alarming projections indicating that the number of diabetes cases is expected to surge in the coming years.
However, Egypt is actively addressing these concerns with strategic measures. The government has emphasized the need to provide necessary medications and has a strategic stock of medicines that can cover local demand for 6-12 months. Additionally, the Egyptian Drug Authority (EDA) diligently monitors the production and distribution of medicines to ensure compliance with international standards.
Furthermore, private pharmaceutical companies like APEX Pharma are investing heavily in expanding their operations. APEX Pharma's plan to construct a new factory in Egypt with an initial investment of over EGP 1 billion and its focus on producing a wide range of pharmaceutical supplies, including tablets and capsules for common diseases like diabetes, highlight the industry's commitment to growth.
The pharmaceutical sector's potential for further expansion is evident in the financial success of companies like El-Nile Co. for Pharmaceuticals and Chemical Industries, which reported a 32.9% year-on-year increase in net profits in fiscal year 2022/2023.
Additionally, Egypt's pharmaceutical industry is diversifying, with Valu and GSK partnering to provide flexible financing solutions for GSK's vaccines, aiming to make healthcare more accessible to a wider demographic and enhance public health.
Finally, Egypt's prominence in the global herbal medicine market, ranking fourth in exports for 2022, underscores its growing influence in alternative medicine. This trend is driven by factors such as affordability, accessibility, and the role of healthcare insurance companies in supporting complementary medicine.
In conclusion, Egypt's pharmaceutical industry in 2023 is marked by impressive growth, strategic advantages, and a commitment to addressing healthcare challenges. With ongoing investments, innovative initiatives, and a focus on both traditional and alternative medicine, Egypt is poised to maintain its leadership position in the MENA region and make significant contributions to the global pharmaceutical landscape.
One of the key factors contributing to Egypt's pharmaceutical dominance is its unique dual role as both the largest producer and consumer of pharmaceuticals in the region. This distinction has enabled Egypt to nurture a robust domestic pharmaceutical industry, not only catering to its own population but also exporting pharmaceutical raw materials worth $400 million annually to the global market.
A strategic advantage that sets Egypt apart as a pharmaceutical powerhouse is its abundant mineral resources, which play a vital role in drug manufacturing. These resources ensure a cost-effective and sustainable production process, making Egypt an attractive destination for pharmaceutical companies seeking to invest in the sector.
Egypt's commitment to further enhancing its pharmaceutical capabilities is evident in initiatives such as securing funding from banks to support research and development (R&D) efforts within local pharmaceutical companies. This investment in R&D is expected to lead to innovative drug development and advanced pharmaceutical technologies, strengthening Egypt's position as a global pharmaceutical leader.
Despite these remarkable achievements, there have been concerns about the shortage of certain medications, especially those used for chronic illnesses like diabetes, blood thinners, and common cold remedies. Egypt faces the challenge of meeting the growing demand for healthcare, particularly in light of alarming projections indicating that the number of diabetes cases is expected to surge in the coming years.
However, Egypt is actively addressing these concerns with strategic measures. The government has emphasized the need to provide necessary medications and has a strategic stock of medicines that can cover local demand for 6-12 months. Additionally, the Egyptian Drug Authority (EDA) diligently monitors the production and distribution of medicines to ensure compliance with international standards.
Furthermore, private pharmaceutical companies like APEX Pharma are investing heavily in expanding their operations. APEX Pharma's plan to construct a new factory in Egypt with an initial investment of over EGP 1 billion and its focus on producing a wide range of pharmaceutical supplies, including tablets and capsules for common diseases like diabetes, highlight the industry's commitment to growth.
The pharmaceutical sector's potential for further expansion is evident in the financial success of companies like El-Nile Co. for Pharmaceuticals and Chemical Industries, which reported a 32.9% year-on-year increase in net profits in fiscal year 2022/2023.
Additionally, Egypt's pharmaceutical industry is diversifying, with Valu and GSK partnering to provide flexible financing solutions for GSK's vaccines, aiming to make healthcare more accessible to a wider demographic and enhance public health.
Finally, Egypt's prominence in the global herbal medicine market, ranking fourth in exports for 2022, underscores its growing influence in alternative medicine. This trend is driven by factors such as affordability, accessibility, and the role of healthcare insurance companies in supporting complementary medicine.
In conclusion, Egypt's pharmaceutical industry in 2023 is marked by impressive growth, strategic advantages, and a commitment to addressing healthcare challenges. With ongoing investments, innovative initiatives, and a focus on both traditional and alternative medicine, Egypt is poised to maintain its leadership position in the MENA region and make significant contributions to the global pharmaceutical landscape.